Shitara K - Search Results

1

A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities.

Shitara K, Kuwana Y, Nakamura K, Tokutake Y, Ohta S, Miyaji H, Hasegawa M, Hanai N. Shitara K, et al. Cancer Immunol Immunother. 1993 Jun;36(6):373-80. doi: 10.1007/BF01742253. Cancer Immunol Immunother. 1993. PMID: 8500110 Free PMC article.

2

Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma.

Niwa R, Shoji-Hosaka E, Sakurada M, Shinkawa T, Uchida K, Nakamura K, Matsushima K, Ueda R, Hanai N, Shitara K. Niwa R, et al. Among authors: shitara k. Cancer Res. 2004 Mar 15;64(6):2127-33. doi: 10.1158/0008-5472.can-03-2068. Cancer Res. 2004. PMID: 15026353

3

Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG.

Shitara K, Fujiwara K, Igarashi S, Ohta S, Furuya A, Nakamura K, Koike M, Hanai N. Shitara K, et al. J Immunol Methods. 1994 Feb 28;169(1):83-92. doi: 10.1016/0022-1759(94)90127-9. J Immunol Methods. 1994. PMID: 8133075

4

Chimeric anti-ganglioside GM2 antibody with antitumor activity.

Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N. Nakamura K, et al. Among authors: shitara k. Cancer Res. 1994 Mar 15;54(6):1511-6. Cancer Res. 1994. PMID: 8137257

5

A new vector for the high level expression of chimeric antibodies in myeloma cells.

Shitara K, Nakamura K, Tokutake-Tanaka Y, Fukushima M, Hanai N. Shitara K, et al. J Immunol Methods. 1994 Jan 3;167(1-2):271-8. doi: 10.1016/0022-1759(94)90096-5. J Immunol Methods. 1994. PMID: 8308283

6

Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody.

Nakamura K, Hanibuchi M, Yano S, Tanaka Y, Fujino I, Inoue M, Takezawa T, Shitara K, Sone S, Hanai N. Nakamura K, et al. Among authors: shitara k. Cancer Res. 1999 Oct 15;59(20):5323-30. Cancer Res. 1999. PMID: 10537316

7

Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis.

Kanazawa J, Ohta S, Shitara K, Fujita F, Fujita M, Hanai N, Akinaga S, Okabe M. Kanazawa J, et al. Among authors: shitara k. Cancer Immunol Immunother. 2000 Jul;49(4-5):253-8. doi: 10.1007/s002620000101. Cancer Immunol Immunother. 2000. PMID: 10941908 Free PMC article.

8

Recombinant antibodies against ganglioside expressed on tumor cells.

Hanai N, Nakamura K, Shitara K. Hanai N, et al. Among authors: shitara k. Cancer Chemother Pharmacol. 2000;46 Suppl:S13-7. doi: 10.1007/pl00014042. Cancer Chemother Pharmacol. 2000. PMID: 10950141

9

Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody.

Nakamura K, Tanaka Y, Fujino I, Hirayama N, Shitara K, Hanai N. Nakamura K, et al. Among authors: shitara k. Mol Immunol. 2000 Dec;37(17):1035-46. doi: 10.1016/s0161-5890(01)00021-9. Mol Immunol. 2000. PMID: 11399321

10

Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions.

Nakamura K, Tanaka Y, Shitara K, Hanai N. Nakamura K, et al. Among authors: shitara k. Cancer Immunol Immunother. 2001 Jul;50(5):275-84. doi: 10.1007/pl00006689. Cancer Immunol Immunother. 2001. PMID: 11499811 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters